GSK and Earvin “Magic” Johnson Partner to Raise Awareness of Risk of RSV in Older AdultsBusiness Wire • 03/14/23
GSK neck and neck with Pfizer in the race to get first RSV jab to marketProactive Investors • 03/02/23
FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risksCNBC • 03/01/23
US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancerPRNewsWire • 02/10/23
GSK's Innovative Specialty Products Need More Insurance Coverage, Still A BuySeeking Alpha • 02/03/23
GSK: Top investment bank has its say after drug giant's better-than-expected resultsProactive Investors • 02/02/23
Pharma Giants GSK, Novo Nordisk Beat Expectations; But Novartis Dives On A Mixed ReportInvestors Business Daily • 02/01/23